Почетна › Рак дојке › Kolorado › Aurora
Kliničke studije za Рак дојке u gradu Aurora, CO
30 studija za Рак дојке traži učesnike na lokacijama u gradu Aurora i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
E-Mindfulness Approaches for Living After Breast Cancer
Тражи се учесникФаза 3
- UCHealth University of Colorado Hospital, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Rocky Mountain Cancer Centers-Aurora, Aurora
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Тражи се учесникФаза 3
- UCHealth University of Colorado Hospital, Aurora
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Тражи се учесникФаза 3
- University of Colorado Anschutz Medical Campus, Aurora
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Тражи се учесникОпсервациона студија
- UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Тражи се учесникФаза 1/2
- University of Colorado Cancer Center, Aurora
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Тражи се учесникФаза 1/2
- University of Colorado Anschutz Medical Campus ( Site 0057), Aurora
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Тражи се учесникФаза 3
- Rocky Mountain Cancer Centers LLP, Aurora
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Тражи се учесникФаза 3
- University of Colorado Anschutz Medical Campus ( Site 0061), Aurora
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Тражи се учесникФаза 3
- University of Colorado Hospital - Cancer Center, Aurora
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- University of Colorado, Aurora
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Тражи се учесникФаза 1/2
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Тражи се учесникФаза 2
- University of Colorado School of Medicine, Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Тражи се учесникФаза 3
- Research Site, Aurora
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Тражи се учесникФаза 3
- Clinical Trial Site, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- University of Colorado Cancer Center, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Тражи се учесникФаза 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Тражи се учесникФаза 2
- University Of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Тражи се учесникФаза 2/3
- Local Institution - 0289, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Colorado Cancer Center, Aurora
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- University of Colorado Cancer Center, Aurora
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Тражи се учесникФаза 3
- UCHealth University of Colorado Hospital, Aurora
Improving Care for Rural Patients With Solid Tumors
Тражи се учесник
- University of Colorado Hospital, Aurora
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
Тражи се учесникФаза 2
- University of Colorado Anschutz Medical Campus, Aurora
The Immune System's Response to Young Women's Breast Cancer
Тражи се учесникОпсервациона студија
- University of Colorado Denver, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Aurora
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Тражи се учесникОпсервациона студија
- Rocky Mountain Cancer Centers, Aurora
- University of Colorado Cancer Center, Aurora
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Тражи се учесникОпсервациона студија
- University of Colorado Cancer Center, Aurora
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Тражи се учесникФаза 3
- Rocky Mountain Cancer Centers - Aurora, Aurora
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- St. Louis, MO63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
Ostale studije u gradu Aurora
- Рак (све врсте)34 студија
- Колоректални карцином33 студија
- Немалоклетни карцином плућа31 студија
- Dijabetes tipa 126 студија
- Метастатски карцином24 студија
- Рак јајника23 студија
- Гојазност20 студија
- Рак плућа19 студија
- Меланом18 студија
- Затајење срца17 студија
- Рак простате17 студија
- Akutna mijeloidna leukemija16 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.